secwatch.observer — SEC 8-K summary
======================================

Issuer:     TriSalus Life Sciences, Inc. (TLSI)
CIK:        0001826667
Form:       8-K
Filed at:   2026-02-09T23:59:59+00:00
Accession:  0001628280-26-006219
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TriSalus Life Sciences appoints Michael Stansky to board, replacing Dr. Desai
-----------------------------------------------------------------------------

- Dr. Arjun "JJ" Desai resigned from the board on February 3, 2026; no disagreement with the company.
- Michael P. Stansky appointed to the board effective February 4, 2026.
- Stansky brings 40 years of investment management and healthcare experience; former Managing Director at Tudor Investment Corp.
- He will serve on the Audit, Compensation, and Science and Technology Committees.
- Stansky currently serves on boards of Insightec and Momentis Surgical; past boards include Mako Surgical and Transmedics.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1826667/000162828026006219/0001628280-26-006219-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1826667/000162828026006219/tlsi-20260203.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-006219

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer